Molecula delivers essential data to the right place at the right time when lives are literally on the line
The amount of data produced and managed in healthcare is mind-boggling. Despite being in the fastest-growing sector and having so much to gain, healthcare companies are historically slow to adopt new data technologies due in large part to compatibility issues with legacy systems and strict regulation compliance requirements. A major challenge facing healthcare organizations of all types, including hospitals, manufacturers, and group practices today is how to harness important data and turn it into more efficient emergency rooms, better patient outcomes, more secure records, predictive medicine, and more.
Molecula for Healthcare
Molecula is an enterprise feature store that simplifies, accelerates, and controls big data access to power machine-scale analytics and AI so organizations and companies can achieve their goals. With Molecula, healthcare-related businesses are able to securely access and perform computations on any and all data at unprecedented speeds, with incredibly low latency, and with a fraction of the hardware.
Early warnings of disease conditions
Leverage vast and complex datasets with machine learning and AI applications to predict whether a disease is likely to present.
Combine demographic, geographic, and socio-economic data along with disease trends and health strategies to prevent unnecessary illness in populations.
Integrate financial and clinical data to reveal inefficiencies and provide insight into the effectiveness of treatment plans.
For hyper-personalized care
Use biological, medical, behavioral, and environmental data to predict health risks and tailor more successful treatments at the individual level.
"As the leader in bringing healthcare to clinical research, Elligo is leveraging the power of data to directly improve the execution of clinical trials. True data virtualization readiness creates the ability to instantly provide synthetic data, novel data access and streamlined analytics. Molecula accelerates our ability to provide those capabilities and insights to our customers, and this partnership begins to fundamentally change the way clinical trials are executed.”
– Michael Ibara, VP Data Science, Elligo
Contact us today to learn more about how Molecula’s feature extraction and storage platform will transform your business. Ask us how you can unlock real-time value and actualize use cases never possible before.